The Scientific Team at Appia Bio is dedicated to advancing the company's mission of developing allogeneic cell therapies. This team conducts cutting-edge research and development using the ACUA technology platform, working on the genetic engineering of CAR-iNKT cells from HSCs. They collaborate on designing, executing, and analyzing experiments to discover novel cell therapies, with a focus on improving the effectiveness and scalability of these treatments to increase patient access across various medical indications.
Antoni Ribas
Scientific Advisor
Colin Flinders
Principal Scientist
Drake Smith
Principal Scientist
Irving Weissman
Scientific Advisor
Jiaji (Victor) Yu
Scientist II
Lanny Gov, Ph.D.
Principal Scientist
Leo Lee
Research Associate II
Margo Roberts
Scientific Advisor
Mitchell Kronenberg
Scientific Advisor
Samantha Bremner
Scientist I
View all